Access to gene therapy for rare diseases when commercialization is not fit for purpose.

Fox T, Bueren J, Candotti F, Fischer A, Aiuti A, Lankester A, Booth C. Access to gene therapy for rare diseases when commercialization is not fit for purpose. Nat Med. 2023.